Explore other therapeutic areas
Ozempic® can be used as long as the product has not been exposed to temperatures below 36 °F or above 86 °F. If Ozempic® was exposed to non-refrigerated temperatures (any temperature above 46 °F), the product must be used or discarded within 56 days. Ozempic® should be inspected for changes such as precipitation, or change in color or clarity that may indicate a loss in potency.1
Recommended Storage Conditions for Ozempic®1
| Before First Use | After First Use | |
|---|---|---|
| Refrigerated (36 °F – 46 °F) | Room Temperature (59 °F – 86 °F) | Refrigerated (36 °F – 46 °F) |
| Until expiration date | 56 days | 56 days |
Ozempic® (semaglutide) tablets 4 mg or 9 mg, Rybelsus® (semaglutide) tablets 7 mg or 14 mg
Rybelsus® and Ozempic® tablets should be stored at 68°F to 77°F (20°C to 25°C); excursions permitted to 59°F to 86°F (15°C to 30°C) (see USP Controlled Room Temperature). Rybelsus® and Ozempic® tablets should be stored and dispensed in the original bottle until use to protect tablets from moisture.
Rybelsus® and Ozempic® tablets should not be stored in any other container. Store Rybelsus® and Ozempic® tablets in a dry place away from moisture.2
Recommended Storage Conditions for Ozempic® / Rybelsus® tablets
| Before First Use | After First Use |
|---|---|
| Room Temperature (68 °F – 77 °F) | Room Temperature (68 °F – 77 °F) |
| Until expiration date | Until expiration date |
Saxenda® can be used as long as the product has not been exposed to temperatures below 36 °F or above 86 °F. If Saxenda® was exposed to non-refrigerated temperatures (any temperature above 46 °F), the product must be used or discarded within 30 days. Saxenda® should be inspected for changes such as precipitation, or change in color or clarity that may indicate a loss in potency.3
Recommended Storage Conditions for Saxenda®3
| Before First Use | After First Use | |
|---|---|---|
| Refrigerated (36 °F – 46 °F) | Room Temperature (59 °F – 86 °F) | Refrigerated (36 °F – 46 °F) |
| Until expiration date | 30 days | 30 days |
Victoza® can be used as long as the product has not been exposed to temperatures below 36 °F or above 86 °F. If unopened Victoza® was exposed to non-refrigerated temperatures (any temperature above 46 °F), the product must be used or discarded within 30 days. Victoza® should be inspected for changes such as precipitation, or change in color or clarity that may indicate a loss in potency.4
Recommended Storage Conditions for Victoza®4
| Before First Use | After First Use | |
|---|---|---|
| Refrigerated (36 °F – 46 °F) | Room Temperature (59 °F – 86 °F) | Refrigerated (36 °F – 46 °F) |
| Until expiration date | 30 days | 30 days |
(semaglutide) injection 1.7 mg, 2.4 mg, 7.2 mg
(semaglutide) tablet 25 mg
Wegovy® injection: Store the Wegovy® single-dose pen in the refrigerator from 2°C to 8°C (36°F to 46°F). If needed, prior to cap removal, the pen can be kept from 8°C to 30°C (46°F to 86°F) up to 28 days. Do not store Wegovy® in the freezer or directly adjacent to the refrigerator cooling element. Do not freeze Wegovy® and do not use if it has been frozen. Protect Wegovy® from light. Wegovy® must be kept in the original carton until time of administration. Discard the Wegovy® pen after use.5
Wegovy® Tablet: Store at 68°F to 77°F; excursions permitted to 59°F to 86°F. Store and dispense Wegovy® tablets in the original bottle. Store Wegovy® tablet in the original bottle until use to protect tablets from moisture. Store Wegovy® tablets in a dry place away from moisture.5
Recommended Storage Conditions for Wegovy® Injection5
| Before First Use | After First Use |
|---|---|
| Refrigerated (36 °F – 46 °F) | 46 °F – 86 °F) |
| Until expiration date | Up to 28 days |
Recommended Storage Conditions for Wegovy® Tablet5
| Before First Use | After First Use |
|---|---|
| Room Temperature (68 °F – 77 °F) | Room Temperature (68 °F – 77 °F) |
| Until expiration date | Until expiration date |
References
Speak to a medical representative
If you are a healthcare provider from the United States, click below to request information directly from the Novo Nordisk Medical Information department. If you are a patient, please visit here to contact us, or call 1-800-727-6500.
Search the Medical Information Database
Novo Nordisk Medical is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products.